InvestorsHub Logo
Followers 97
Posts 128742
Boards Moderated 1
Alias Born 07/24/2016

Re: None

Wednesday, 05/04/2022 9:05:33 AM

Wednesday, May 04, 2022 9:05:33 AM

Post# of 32852
$NBIO Mr. Carrick stated,

"The Company is moving forward as expected with our Phase I Clinical Trial. In the process, we are learning a lot about PTB. We believe that, as we progress forward with the phase I Clinical Trial and move into phase II, achievement of our milestones will drive significant value for the Company and our shareholders."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.